Predictors of neurodegeneration differ between cognitively normal and subsequently impaired older adults
暂无分享,去创建一个
Christos Davatzikos | Susan M. Resnick | Luigi Ferrucci | Jimit Doshi | Lori Beason-Held | Guray Erus | Nicole M. Armstrong | L. Ferrucci | S. Resnick | C. Davatzikos | Y. An | G. Erus | J. Doshi | L. Beason-Held | Yang An | N. Armstrong
[1] Christos Davatzikos,et al. Longitudinally and inter-site consistent multi-atlas based parcellation of brain anatomy using harmonized atlases , 2018, NeuroImage.
[2] C. Jack,et al. Age and sex specific prevalences of cerebral β-amyloidosis, tauopathy and neurodegeneration among clinically normal individuals aged 50-95 years: a cross-sectional study , 2017, The Lancet Neurology.
[3] A. Rahmim,et al. Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition , 2017, JAMA.
[4] Christos Davatzikos,et al. MUSE: MUlti-atlas region Segmentation utilizing Ensembles of registration algorithms and parameters, and locally optimal atlas selection , 2016, NeuroImage.
[5] J. Schneider,et al. Vascular contributions to cognitive impairment and dementia including Alzheimer's disease , 2015, Alzheimer's & Dementia.
[6] Susan M. Resnick,et al. Greater cortical thinning in normal older adults predicts later cognitive impairment , 2015, Neurobiology of Aging.
[7] Orla Hardiman,et al. Presymptomatic and longitudinal neuroimaging in neurodegeneration—from snapshots to motion picture: a systematic review , 2015, Journal of Neurology, Neurosurgery & Psychiatry.
[8] Rena Li,et al. Sex differences in cognitive impairment and Alzheimer’s disease , 2014, Frontiers in Neuroendocrinology.
[9] A. Dale,et al. Brain Changes in Older Adults at Very Low Risk for Alzheimer's Disease , 2013, The Journal of Neuroscience.
[10] B. Dickerson,et al. MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults , 2012, Neurology.
[11] B. Zlokovic. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders , 2011, Nature Reviews Neuroscience.
[12] C. DeCarli,et al. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline , 2011, Alzheimer's & Dementia.
[13] D. Selkoe. Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.
[14] Ulman Lindenberger,et al. Trajectories of brain aging in middle-aged and older adults: Regional and individual differences , 2010, NeuroImage.
[15] C. Jack,et al. MRI and CSF biomarkers in normal, MCI, and AD subjects , 2009, Neurology.
[16] J. Molinuevo,et al. Brain structure and function related to cognitive reserve variables in normal aging, mild cognitive impairment and Alzheimer's disease , 2009, Neurobiology of Aging.
[17] S. Rubin,et al. Predictors of maintaining cognitive function in older adults , 2009, Neurology.
[18] S. Resnick,et al. Longitudinal pattern of regional brain volume change differentiates normal aging from MCI , 2009, Neurology.
[19] M. Weiner,et al. Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease* , 2009, Brain : a journal of neurology.
[20] Olga Pletnikova,et al. Effect of infarcts on dementia in the Baltimore longitudinal study of aging , 2008, Annals of neurology.
[21] F. Pasquier,et al. Risk profiles for mild cognitive impairment and progression to dementia are gender specific , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.
[22] O. Hanon,et al. Vascular risk factors, cognitve decline, and dementia , 2008, Vascular health and risk management.
[23] David A. Bennett,et al. Mixed brain pathologies account for most dementia cases in community-dwelling older persons , 2007, Neurology.
[24] C. Jack,et al. 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. , 2007, Brain : a journal of neurology.
[25] C. Jack,et al. Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia. , 2007, Archives of neurology.
[26] F. Panza,et al. Lipid metabolism in cognitive decline and dementia , 2006, Brain Research Reviews.
[27] P. Scheltens,et al. Age, Hypertension, and Lacunar Stroke Are the Major Determinants of the Severity of Age-Related White Matter Changes , 2006, Cerebrovascular Diseases.
[28] Charles DeCarli,et al. Sex, Apolipoprotein E ε4 Status, and Hippocampal Volume in Mild Cognitive Impairment , 2005 .
[29] Nick C. Fox,et al. Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease , 2004, NeuroImage.
[30] Karen M Rodrigue,et al. Hypertension and the brain: vulnerability of the prefrontal regions and executive functions. , 2003, Behavioral neuroscience.
[31] S. Resnick,et al. Longitudinal Magnetic Resonance Imaging Studies of Older Adults: A Shrinking Brain , 2003, The Journal of Neuroscience.
[32] J Tuomilehto,et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study , 2001, BMJ.
[33] R Brookmeyer,et al. Age-specific incidence rates of Alzheimer’s disease , 2000, Neurology.
[34] K. Hall,et al. Serum cholesterol, APOE genotype, and the risk of Alzheimer’s disease: A population-based study of African Americans , 2000, Neurology.
[35] J. Morris. The Clinical Dementia Rating (CDR) , 1993, Neurology.
[36] D. Grossi,et al. Plasma lipids and geriatric assessment in a very aged population of south Italy. , 1989, Atherosclerosis.
[37] S. Bellur. Alzheimer's Disease: Senile Dementia and Related Disorders , 1979 .
[38] R. Levy,et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.